Jeff Edelson, MD, FRCPC, MHSc
Dr. Jeff Edelson is a pulmonologist with over 30 years of clinical practice, research and management experience. Throughout his career, Jeff has demonstrated a strong track record of collaborative strategic and operational achievement and is recognized as a strong creative problem solver, analyst, seasoned technical product expert, leader of multifunctional and alliance teams and effective communicator. He has served BioAdvance as an EIR / Scientific Liason since May 2008. Dr. Edelson is the principal of AEQuanimitas Consulting LLC, which focuses on clinical and regulatory development strategy, providing services to development organizations and investors. His prior experience includes leadership positions at SmithKline Beecham, where he served as group director, pulmonary clinical research, development and medical affairs, Therion Biologics, Aventis, Ikano Therapeutics and Johnson & Johnson PRD where he last served as Vice President and Therapeutic Area Head, Novel Therapeutics. He recently served as chief medical officer and head of research and development at BioMotiv LLC, a mission driven drug development accelerator. Prior to working in biotech and pharma, he was a clinician / scientist with a research program focused on acute lung injury and was the founding Director of Research and Academic Affairs at St. Michael’s Hospital in Toronto. Dr. Edelson holds M.D. and MHSc (health administration) degrees from the University of Toronto and fellowships in Internal Medicine and Respirology (Pulmonary and Critical Care Medicine).